Codeage Liposomal NMN Review (2026): Does the Delivery System Justify the Price?

Who Is Codeage?

Codeage is a Los Angeles-based supplement company with a broad product portfolio spanning liposomal vitamins, collagen, probiotics, organ supplements, and longevity compounds. Unlike single-focus brands like PartiQlar (which sells only NMN), Codeage offers over 100 SKUs across dozens of categories. NMN is one product line among many.

The brand's positioning centers on "advanced delivery systems," particularly liposomal formulations across its product range. Codeage manufactures in the USA using globally sourced ingredients in cGMP-certified facilities and holds NSF certification. The company sells through its own website, Amazon, Target, Ulta, and other retailers, giving it wider distribution than direct-to-consumer-only brands.

Three NMN Products, Three Different Value Propositions

Codeage's NMN line is more complex than most competitors because it is not a single product. Understanding the differences between the three options is essential before purchasing.

Product	NMN	Companion Ingredients	Serving	Price	$/mg NMN
Liposomal NMN (basic)	207.5 mg	TMG 42.5 mg	1 cap	$39.99/30	$0.0064
Liposomal NMN 1000	1,000 mg	TMG (dose not listed)	Multi-cap	$89.99	~$0.0030
Liposomal NMN Platinum	500 mg	Resveratrol 150 mg, Quercetin 250 mg, TMG 85 mg, B2, B12	3 caps	$79.99/90	$0.0053

The basic version at 207.5 mg NMN is below the 250 mg minimum used in the Yoshino trial (Yoshino et al., 2021, PMID: 33888596) and falls in the sub-clinical range for most published endpoints. At $0.0064/mg, it is also one of the most expensive NMN products per milligram on the market, tied with Cymbiotika. The Platinum version at 500 mg and the 1000 version at 1,000 mg are within the clinical range but require 3 capsules per serving, increasing capsule count relative to single-capsule 500 mg competitors.

The Liposomal Delivery Claim: What the Evidence Actually Shows

Codeage's central differentiator is its "Helix Liposomal Delivery" system using phospholipids from non-GMO sunflower lecithin, including phosphatidylcholine. The marketing implies this enhances NMN absorption compared to standard capsules. This claim requires scrutiny.

Liposomal delivery works by encapsulating an active ingredient inside a lipid bilayer (liposome), which can protect the molecule from degradation in the stomach and potentially improve absorption through the intestinal wall. This approach has proven effective for certain nutrients, notably vitamin C, where liposomal formulations have demonstrated improved bioavailability in published human trials.

For NMN specifically, no published human trial has compared liposomal NMN absorption to standard NMN capsules. The presumption that liposomal delivery improves NMN bioavailability is extrapolated from data on other molecules, not demonstrated for NMN itself. We discuss this evidence gap in detail in our Liposomal NAD+ and NMN guide.

The 2026 Nature Metabolism study by Christen and colleagues adds a complicating layer. Their data shows that oral NMN is largely converted to nicotinic acid by gut bacteria, and it is this bacterial metabolite (not intact NMN) that drives the sustained NAD+ elevation in blood (Christen et al., 2026, PMID: 41540253). If this gut-dependent mechanism is the primary pathway by which oral NMN works, then a liposomal delivery system designed to bypass gut degradation might inadvertently bypass the very conversion step that makes NMN effective. This is speculative, as no study has tested liposomal NMN against this specific mechanistic question. But it raises a theoretical concern that the standard NMN marketing narrative (protect the molecule from stomach acid, deliver it intact) may not align with how NMN actually produces its NAD+ boosting effect in humans.

The Platinum Formula: Companion Ingredients Evaluated

The NMN Platinum version is the most interesting Codeage product because it combines NMN with several companion ingredients at doses worth evaluating.

Trans-resveratrol (150 mg): This sits at the very bottom of the clinically studied range (150-500 mg). A 2025 meta-analysis of 11 RCTs found no significant impact of resveratrol on SIRT1 gene expression in humans, even at higher doses (Mansouri et al., 2025, PMID: 40158656). At 150 mg, Codeage delivers more resveratrol than Cymbiotika (100 mg) but still below most positive trial doses. See our NMN and Resveratrol guide for the full evidence breakdown.

Quercetin (250 mg from Japanese Sophora): Quercetin is a flavonoid with senolytic properties (it can help clear damaged cells). At 250 mg, this is below the 500-1,000 mg range used in most quercetin clinical trials, though a 2018 safety review noted that quercetin at doses up to 1,000 mg/day is generally well-tolerated (Andres et al., 2018, PMID: 29127724). The inclusion adds a senolytic angle that no other reviewed NMN product offers.

Betaine anhydrous (TMG, 85 mg): This is a token dose. The clinical evidence for TMG's effect on homocysteine requires 4,000-6,000 mg daily. At 85 mg, TMG is present at 1.4-2.1% of the clinically effective range. Compare this to Dr. Love NMN at 400 mg (still only 7-10% of clinical range). Codeage's TMG inclusion is a label ingredient, not a functional dose.

Riboflavin-5'-phosphate (B2, 1 mg) and Methylcobalamin (B12, 250 mcg): These are reasonable supplemental doses of activated B vitamins. B2 is a cofactor in energy metabolism, and methylated B12 supports methylation pathways. At these doses, they are functional additions, though they are inexpensive vitamins available in any multivitamin.

The Three-Capsule Problem

The NMN Platinum version requires three capsules per serving to deliver 500 mg NMN. This is a practical consideration that most reviews overlook. Supplement compliance (actually taking the product daily over months) correlates with serving simplicity. One capsule per day is easier to maintain than three, especially when the three capsules need to be taken together rather than spread across the day.

For comparison, PartiQlar, Nutricost, and YourHealthier NMN all deliver 500 mg in a single capsule. Force Factor also uses a single capsule. Codeage's three-capsule serving means a 90-capsule bottle lasts 30 days, the same duration as a 30-capsule bottle from a single-capsule competitor. The bottle looks like more, but the servings are identical.

The three-capsule format also has a cost implication for travelers and people who use pill organizers. Three slots per day dedicated to NMN versus one slot affects how much room remains for other supplements. This is a minor point for some consumers and a meaningful one for others, particularly those who already take multiple daily supplements.

The Quercetin Angle: Codeage's Unique Addition

Among all the NMN products we have reviewed, Codeage Platinum is the only one that includes quercetin. This is worth examining because quercetin has a distinct mechanism that is genuinely complementary to NMN supplementation, at least in theory.

Quercetin is a flavonoid found in onions, apples, and green tea. In the longevity research space, it has attracted attention primarily as a senolytic agent, a compound that helps clear senescent cells (old, damaged cells that accumulate with aging and secrete inflammatory signals). The most studied senolytic combination is dasatinib + quercetin (D+Q), which has shown senolytic effects in human adipose tissue and in clinical trials targeting idiopathic pulmonary fibrosis.

At 250 mg, Codeage's quercetin dose is below the 500-1,000 mg/day range used in most quercetin supplementation studies. A 2018 safety review in Molecular Nutrition & Food Research concluded that quercetin at doses up to 1,000 mg/day is generally well-tolerated in humans, with limited bioavailability being the primary challenge rather than safety concerns (Andres et al., 2018, PMID: 29127724). The low oral bioavailability of quercetin (estimated at 2-20% depending on the source and formulation) means that much of an oral dose is metabolized before reaching systemic circulation.

The combination of NMN (which supports NAD+ and cellular repair) with quercetin (which targets senescent cell clearance) addresses two distinct hallmarks of aging through different mechanisms. This is a more sophisticated formula rationale than simply stacking NMN with resveratrol because of the Sinclair protocol. However, the 250 mg quercetin dose and the absence of dasatinib (a prescription drug) mean that Codeage Platinum's senolytic potential is speculative at best. The quercetin is better understood as an antioxidant and anti-inflammatory contribution than as a functional senolytic at this dose.

Product Line Confusion: A Real Consumer Problem

Codeage's three-product NMN line creates a genuine consumer confusion issue. Searching "Codeage NMN" on Amazon returns all three products, often in visually similar packaging. The differences in NMN dose are dramatic (207.5 mg vs 500 mg vs 1,000 mg), and a consumer who grabs the cheapest option ($39.99 basic) may not realize they are getting a sub-clinical NMN dose.

The basic version at 207.5 mg is particularly problematic. It sits below the minimum dose validated in any published clinical trial (250 mg in the Yoshino study). At $39.99 for 30 capsules, it costs $1.33/day for 207.5 mg, which is $0.0064/mg. By contrast, the NMN 1000 at $89.99 delivers 1,000 mg/day at approximately $0.0030/mg, less than half the cost per milligram. The basic version is both the worst dose and the worst value in the lineup.

If you are considering Codeage NMN, the Platinum (500 mg, multi-ingredient) or the NMN 1000 (1,000 mg, NMN + TMG only) are the only versions worth evaluating. The basic version should be avoided.

Long-Term Cost by Product Tier

Because Codeage offers three NMN products, the annual cost varies significantly depending on which one you choose:

Codeage Product	NMN/Day	Monthly	Annual
Basic (avoid)	207.5 mg	$39.99	$480
Platinum	500 mg	$79.99	$960
NMN 1000	1,000 mg	$89.99	$1,080

For context, a year of YourHealthier NMN at 500 mg costs $360. Codeage Platinum at the same NMN dose costs $960, a 2.7x premium. That premium buys liposomal delivery (unproven for NMN), 150 mg resveratrol (below most trial doses), 250 mg quercetin (below senolytic trial doses), 85 mg TMG (negligible), and B vitamins (available in any multivitamin for $5/month).

The NMN 1000 at $1,080/year delivers a dose that the Yi trial data suggests is past the point of diminishing returns for NAD+ elevation (Yi et al., 2023, PMID: 36482258). At 500 mg, you capture most of the dose-response curve's benefit. Going to 1,000 mg adds marginal NAD+ elevation at double the cost. For most consumers, the cost-benefit math favors 500 mg from a verified source.

Where Codeage Fits in the NMN Market

Codeage occupies a unique position in the NMN market: it is a mainstream supplement brand (sold at Target, Ulta, Amazon) that has entered the longevity space with a multi-product NMN line. Unlike longevity-focused brands like PartiQlar or Wonderfeel, Codeage treats NMN as one product category among many. This has implications for focus and expertise.

The advantage of a mainstream brand entering longevity is distribution reach and brand recognition. Consumers who encounter NMN for the first time at Target or Ulta may choose Codeage because the brand is already familiar. The disadvantage is that NMN is not Codeage's core competency. The company does not fund NMN research, does not name its NMN supplier, and does not publish batch-specific COAs. Its differentiator (liposomal delivery) is a technology claim rather than a purity or transparency claim.

For consumers who prioritize convenience and brand familiarity, Codeage is a reasonable entry point. For consumers who prioritize evidence, transparency, and cost-efficiency, the verified mid-tier brands (PartiQlar, ProHealth, YourHealthier) offer more of what matters at a lower price.

Transparency Gaps

Codeage does not publicly name its NMN raw material supplier. Unlike PartiQlar (which identifies EffePharm/Uthever) or ProHealth (which also uses named Uthever), Codeage's NMN source is undisclosed. The company also does not publish batch-specific COAs on its product pages, instead relying on its NSF certification and cGMP manufacturing as trust signals.

This is not unusual in the supplement industry, but it places Codeage below the transparency standard set by brands that name their supplier and publish batch testing. SuppCo's note that "product-specific testing is not currently verified by SuppCo" applies here, meaning no independent lab has purchased and tested a Codeage NMN bottle to confirm label accuracy.

Safety Across All Three Dose Levels

NMN safety has been evaluated across the full dose range that Codeage's three products span (207.5 mg to 1,000 mg). The evidence is reassuring at all levels.

At the low end (207.5 mg, basic version), this dose is below the minimum tested in any published trial but well within the range of normal dietary NAD+ precursor intake. No safety concern exists at this dose; the issue is efficacy, not safety.

At 500 mg (Platinum), this dose has been directly tested in multiple human RCTs. A 2023 review of all completed NMN human trials confirmed consistent tolerability at this dose with no serious adverse events (Song et al., 2023, PMID: 37619764). A 2025 meta-analysis of 12 NMN trials with 513 participants found the same safety profile alongside reliable NAD+ elevation (Zhang et al., 2025, PMID: 39116016).

At 1,000 mg (NMN 1000), the Fukamizu safety trial tested up to 1,250 mg daily for four weeks without adverse events (Fukamizu et al., 2022, PMID: 36002548). The main consideration at this dose is not safety but diminishing returns: the Yi dose-ranging data suggests that NAD+ elevation plateaus above 600 mg, meaning additional NMN beyond this point may not produce proportionally more NAD+ (Yi et al., 2023, PMID: 36482258).

The companion ingredients in the Platinum version (resveratrol, quercetin, TMG, B vitamins) have their own safety profiles. Trans-resveratrol at 150 mg is well below doses that cause gastrointestinal effects (typically above 1,000 mg). Quercetin at 250 mg is within the well-tolerated range per the Andres 2018 review (Andres et al., 2018, PMID: 29127724). TMG at 85 mg and B vitamins at the listed doses present no known safety concerns.

The liposomal delivery system itself (sunflower lecithin phospholipids) is a food-grade ingredient used widely in supplements and food manufacturing. Phosphatidylcholine, the primary phospholipid in sunflower lecithin, has a long safety record in human consumption.

For a complete discussion of NMN side effects across all published trials, see our NMN side effects guide.

What Would Prove Liposomal NMN Works Better?

To be fair to Codeage's central claim, here is what a definitive study would need to show to validate liposomal NMN as superior to standard NMN capsules:

Study design: A randomized, double-blind, crossover or parallel-group trial in healthy humans comparing liposomal NMN capsules to standard NMN capsules at the same dose (e.g., 500 mg/day) for at least 14 days. The study would need to measure blood NAD+ levels as the primary endpoint, with pharmacokinetic measurements (blood NMN levels at multiple time points) as a secondary endpoint.

What it would need to show: Statistically significantly higher blood NAD+ elevation (and/or faster NAD+ elevation) in the liposomal group compared to the standard capsule group at the same NMN dose. Ideally, it would also measure whether the liposomal form changes the gut microbial conversion pattern identified in the Christen 2026 study (Christen et al., 2026, PMID: 41540253).

No such study exists. Until it does, "liposomal delivery" as applied to NMN is a technology looking for evidence rather than evidence looking for a technology. This does not mean liposomal NMN is inferior to standard NMN. It means the premium charged for the delivery system is based on theoretical advantages extrapolated from other molecules, not from NMN-specific human data. Consumers paying for Codeage's Helix Liposomal Delivery are paying for a hypothesis, not a demonstrated benefit.

Who Should Consider Codeage NMN

Codeage NMN makes the most sense for three specific consumer profiles, and each maps to a different product in the lineup.

You want a multi-ingredient NAD+ and longevity stack in one purchase (Platinum). The Platinum version is the only reviewed NMN product that combines NMN with quercetin, a molecule with senolytic research interest. The resveratrol, TMG, and B vitamin additions round out a formula that addresses multiple longevity pathways (NAD+ replenishment, sirtuin activation, senescent cell clearance, methylation, energy metabolism cofactors) in a single serving. The 500 mg NMN dose is clinically validated, and the companion ingredients, while mostly below optimal individual doses, provide directional support. If you would otherwise buy 4-5 separate supplements and want the convenience of one product, Platinum is a reasonable consolidation play at $79.99/month.

You want a high NMN dose with liposomal delivery (NMN 1000). The NMN 1000 delivers 1,000 mg with TMG and liposomal encapsulation. The dose is safe per the Fukamizu trial (Fukamizu et al., 2022, PMID: 36002548), though the Yi dose-ranging data suggests the NAD+ response plateaus above 600 mg (Yi et al., 2023, PMID: 36482258). For consumers who believe in the liposomal delivery hypothesis and want the highest available NMN dose, this product delivers. At $89.99/month it is expensive, but the cost per milligram ($0.003) is competitive with other 1,000 mg NMN products.

You are already a Codeage customer and trust the brand ecosystem. Consumers who use other Codeage products (liposomal vitamins, collagen, probiotics) may prefer to consolidate their supplement purchases with a single brand. The NSF certification and cGMP manufacturing provide a quality floor. If you are comfortable with the brand's general transparency level (no batch COAs, no named NMN source), adding their NMN to your existing Codeage stack is a logical extension.

The basic version at 207.5 mg NMN is hard to recommend for anyone. The dose is below the minimum tested in any published clinical trial. The price per milligram is among the highest in the market. The TMG at 42.5 mg is negligible. If you are considering this product, you would be better served by the Platinum version at 500 mg for $40 more per month, or by a competitor's 500 mg product at a lower price.

Who Should Look Elsewhere

If transparency is your priority: Brands like PartiQlar and ProHealth name their NMN supplier (EffePharm/Uthever), publish batch-specific COAs, and provide a full supply chain audit trail. Codeage offers none of this. At the price Codeage charges, the absence of these transparency measures is a meaningful gap.

If cost-per-milligram matters: Nutricost delivers 500 mg at $0.90/day, Force Factor at $0.83/day, and YourHealthier NMN at $1.00/day. Codeage Platinum at 500 mg costs $2.67/day. The difference is not explained by the companion ingredients (which can be purchased separately for less than $1/day) or the liposomal delivery (which has no NMN-specific evidence).

If you want proven delivery and nothing else: The clinical trials that proved NMN works in humans used standard capsules, not liposomal formulations. YourHealthier NMN provides 500 mg in the same delivery format validated by 12+ human RCTs, with a published COA, at $29.99/month. No liposomal premium. No unproven absorption claims. Just the molecule the trials tested.

For a ranked comparison of all reviewed NMN products, see our Best NMN Supplements (2026) guide.

Frequently Asked Questions

Does liposomal NMN absorb better than regular NMN?

No published human study has compared liposomal NMN absorption to standard NMN capsules. The claim is extrapolated from liposomal data on other molecules (primarily vitamin C). Additionally, the 2026 Nature Metabolism finding that gut bacteria convert oral NMN to nicotinic acid before it raises systemic NAD+ (Christen et al., 2026, PMID: 41540253) raises the question of whether bypassing gut exposure with liposomal delivery might reduce, rather than enhance, NMN's effectiveness. This remains unresolved.

Which Codeage NMN product is the best value?

On a cost-per-milligram basis, the NMN 1000 version ($89.99 for ~1,000 mg/day) is better value than the Platinum ($79.99 for 500 mg/day). The basic version (207.5 mg for $39.99) is the worst value per milligram. However, the Platinum version includes companion ingredients (resveratrol, quercetin, B vitamins) that add functional value if those ingredients matter to you.

Does Codeage NMN have a COA?

Codeage holds NSF certification and manufactures in cGMP-certified facilities, but does not publish batch-specific Certificates of Analysis on its product pages. This is a lower transparency standard than brands like PartiQlar, ProHealth, or YourHealthier, all of which publish or make available batch-level testing data.

Is 207.5 mg of NMN enough?

Probably not for the effects demonstrated in clinical trials. The lowest dose shown to produce meaningful clinical outcomes is 250 mg in the Yoshino trial (Yoshino et al., 2021, PMID: 33888596). At 207.5 mg, Codeage's basic NMN sits below this threshold. For dose-response evidence, see our NMN dosage guide.

Is Codeage NMN sold at Target and Ulta?

Yes. Codeage NMN products are available at Target, Ulta, Amazon, and other retailers in addition to the brand's own website. This wide distribution is unusual for NMN supplements; most verified NMN brands sell direct-to-consumer only. The retail availability makes Codeage more accessible but also means the product passes through more supply chain hands before reaching the consumer.

Should I choose the Platinum or the NMN 1000?

It depends on what you want. The Platinum gives you 500 mg NMN with five companion ingredients (resveratrol, quercetin, TMG, B2, B12) for $79.99/month. The NMN 1000 gives you 1,000 mg NMN with TMG only for $89.99/month. If you want companion ingredients and are comfortable with 500 mg NMN, choose Platinum. If you want the highest NMN dose and do not need the extras, choose NMN 1000. If cost-per-milligram is the priority, the NMN 1000 is the better value.

Does Codeage name its NMN supplier?

No. Unlike PartiQlar and ProHealth, which identify EffePharm/Uthever as their NMN source, Codeage does not disclose its NMN raw material supplier. This means consumers cannot trace the NMN in Codeage products back to a specific manufacturer or to any published clinical trial data on the raw material.

How does Codeage NMN compare to Cymbiotika NMN?

Both position themselves as premium multi-ingredient NMN products. Cymbiotika offers 400 mg NMN with apigenin, green tea, resveratrol, and green coffee bean at $77/month with a SuppCo score of 9.63. Codeage Platinum offers 500 mg NMN with resveratrol, quercetin, TMG, and B vitamins at $79.99/month. Codeage provides more NMN (500 vs 400 mg) and more resveratrol (150 vs 100 mg). Cymbiotika provides higher trust verification (SuppCo 9.63 vs no Codeage product-specific score) and the unique apigenin CD38-inhibitor angle.

References

1. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PMID: 33888596
2. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. Geroscience. 2023;45(1):29-43. PMID: 36482258
3. Fukamizu Y, Uchida Y, Shigekawa A, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12(1):14442. PMID: 36002548
4. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Adv Nutr. 2023;14(6):1416-1435. PMID: 37619764
5. Christen S, Cuenoud B, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026. PMID: 41540253
6. Mansouri F, et al. Impact of resveratrol supplementation on human sirtuin 1 gene expression: a systematic review and meta-analysis. J Acad Nutr Diet. 2025. PMID: 40158656
7. Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62(1). PMID: 29127724
8. Zhang J, Poon ETC, Wong SHS, et al. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism: a systematic review with meta-analysis. Crit Rev Food Sci Nutr. 2025. PMID: 39116016

Disclaimer: This article is for informational purposes only and does not constitute medical advice. NMN supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before beginning any supplement regimen.